Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Profit After Tax (2010 - 2026)

Updated

Elite Pharmaceuticals' Profit After Tax came in at $5.91 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.88 million a year earlier and down 68.0% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Profit After Tax (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Profit After Tax of $56.67 million; for FY2026 (ended Mar 31, 2026), it was $44.87 million.

  • Profit After Tax carries a five-year compound annual growth rate of 61.0% (FY2021 to FY2026).
  • Going back by fiscal year, Profit After Tax was -$4.4 million in FY2025, $20.15 million in FY2024 (+465.6%), $3.56 million in FY2023 (-55.7%) and $8.04 million in FY2022 (+94.0%).
  • The five-year range for quarterly Profit After Tax is -$11.04 million (fiscal Q2 2025) to $18.59 million (fiscal Q3 2026).
  • The fastest year-over-year change in Profit After Tax over five years came in fiscal Q2 2024 (growth of 885.7%), and the weakest in fiscal Q1 2023 (a decline of 80.1%).
  • Business Quant data shows ELTP's Profit After Tax at $18.46 million (Q4 2026), $18.59 million (Q3 2026) and $13.7 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 5.53 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 3.62 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.51 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -246.00 Mn
10 Elite Pharmaceuticals 258.43 Mn 140.10 Mn 13.51 Mn 5.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.91 Mn
Mar 31, 2026 18.46 Mn
Dec 31, 2025 18.59 Mn
Sep 30, 2025 13.70 Mn
Jun 30, 2025 -5.88 Mn
Mar 31, 2025 16.91 Mn
Dec 31, 2024 -10.89 Mn
Sep 30, 2024 -11.04 Mn
Jun 30, 2024 615,773.00
Mar 31, 2024 3.36 Mn
Dec 31, 2023 706,354.00
Sep 30, 2023 14.93 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 -1.23 Mn
Dec 31, 2022 2.97 Mn
Sep 30, 2022 1.52 Mn
Jun 30, 2022 305,883.00
Mar 31, 2022 2.43 Mn
Dec 31, 2021 2.28 Mn
Sep 30, 2021 1.79 Mn
API Access

Elite Pharmaceuticals Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ELTP&period=max&api_key=YOUR_API_KEY